SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4jrn'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1A52_B_ESTB2_1 (ESTROGEN RECEPTOR)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	5 / 10	ALA A 269 LEU A 278 MET A 356 ARG A 250 LEU A 258	None None ANP A 601 (-3.3A) None ANP A 601 ( 4.6A)	1.46A	1a52B-4jrnA: undetectable	1a52B-4jrnA: 20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KVL_A_CLSA371_1 (BETA-LACTAMASE)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	5 / 10	GLY A 487 GLN A 505 TYR A 474 TYR A 491 THR A 483	None	1.43A	1kvlA-4jrnA: undetectable	1kvlA-4jrnA: 21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MUO_A_ADNA1_1 (AURORA-RELATED KINASE 1)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	6 / 9	LEU A 258 GLY A 259 VAL A 266 ALA A 279 ALA A 359 LEU A 416	ANP A 601 ( 4.6A) ANP A 601 (-3.4A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 (-3.5A) ANP A 601 ( 4.9A)	0.86A	1muoA-4jrnA: 6.0	1muoA-4jrnA: 26.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XBB_A_STIA1_1 (TYROSINE-PROTEIN KINASE SYK)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	6 / 9	LEU A 258 VAL A 266 ALA A 279 MET A 356 ALA A 359 LEU A 416	ANP A 601 ( 4.6A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 (-3.3A) ANP A 601 (-3.5A) ANP A 601 ( 4.9A)	0.89A	1xbbA-4jrnA: 21.8	1xbbA-4jrnA: 21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DU8_B_BEZB1352_0 (D-AMINO-ACID OXIDASE)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	4 / 6	LEU A 389 TYR A 388 ILE A 204 ARG A 321	None	0.90A	2du8B-4jrnA: undetectable	2du8B-4jrnA: 24.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EVA_A_ADNA498_1 (TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	7 / 11	GLY A 259 GLY A 261 VAL A 266 ALA A 279 MET A 356 ALA A 359 LEU A 416	ANP A 601 (-3.4A) ANP A 601 ( 3.3A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 (-3.3A) ANP A 601 (-3.5A) ANP A 601 ( 4.9A)	0.75A	2evaA-4jrnA: 18.2	2evaA-4jrnA: 24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_D_MIXD3539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	7 / 12	LEU A 258 GLY A 259 GLY A 261 VAL A 266 ALA A 279 MET A 356 LYS A 411	ANP A 601 ( 4.6A) ANP A 601 (-3.4A) ANP A 601 ( 3.3A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 (-3.3A) MG A 602 (-3.6A)	0.86A	2fumD-4jrnA: 19.6	2fumD-4jrnA: 26.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ITY_A_IREA2020_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	9 / 12	LEU A 258 GLY A 259 VAL A 266 ALA A 279 LYS A 281 GLU A 300 LEU A 354 LEU A 416 ASP A 427	ANP A 601 ( 4.6A) ANP A 601 (-3.4A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 (-3.2A) None None ANP A 601 ( 4.9A) MG A 603 ( 2.0A)	1.02A	2ityA-4jrnA: 21.0	2ityA-4jrnA: 24.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XP2_A_VGHA9000_1 (TYROSINE-PROTEIN KINASE RECEPTOR)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	6 / 9	LEU A 258 VAL A 266 ALA A 279 LEU A 416 GLY A 426 ASP A 427	ANP A 601 ( 4.6A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 ( 4.9A) None MG A 603 ( 2.0A)	0.60A	2xp2A-4jrnA: 19.9	2xp2A-4jrnA: 23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A9E_B_REAB1_1 (RETINOIC ACID RECEPTOR ALPHA)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	5 / 11	PHE A 322 ILE A 405 PHE A 307 SER A 308 PHE A 428	None	1.13A	3a9eB-4jrnA: undetectable	3a9eB-4jrnA: 22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DH0_A_SAMA220_1 (SAM DEPENDENT METHYLTRANSFERASE)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	4 / 8	ARG A 299 ASP A 465 GLN A 468 GLU A 450	None	1.13A	3dh0A-4jrnA: undetectable	3dh0A-4jrnA: 21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FUP_B_MI1B1_1 (TYROSINE-PROTEIN KINASE JAK2)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	7 / 12	LEU A 258 GLY A 259 GLY A 261 VAL A 266 ALA A 279 LYS A 281 MET A 356	ANP A 601 ( 4.6A) ANP A 601 (-3.4A) ANP A 601 ( 3.3A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 (-3.2A) ANP A 601 (-3.3A)	0.54A	3fupB-4jrnA: 20.6	3fupB-4jrnA: 19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SUF_B_SUEB1201_2 (NS3 PROTEASE, NS4A PROTEIN)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	3 / 3	TYR A 267 LEU A 417 ARG A 358	None	0.67A	3sufB-4jrnA: undetectable	3sufB-4jrnA: 20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZBF_A_VGHA3000_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	6 / 12	LEU A 258 ALA A 279 ASP A 362 LEU A 416 GLY A 426 ASP A 427	ANP A 601 ( 4.6A) ANP A 601 ( 3.9A) ANP A 601 (-4.1A) ANP A 601 ( 4.9A) None MG A 603 ( 2.0A)	0.56A	3zbfA-4jrnA: 21.1	3zbfA-4jrnA: 23.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ANS_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	6 / 9	LEU A 258 VAL A 266 ALA A 279 MET A 356 LEU A 416 ASP A 427	ANP A 601 ( 4.6A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 (-3.3A) ANP A 601 ( 4.9A) MG A 603 ( 2.0A)	0.53A	4ansA-4jrnA: 19.8	4ansA-4jrnA: 24.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MKC_A_4MKA1503_1 (ALK TYROSINE KINASE RECEPTOR)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	7 / 12	LEU A 258 VAL A 266 ALA A 279 LYS A 281 ASP A 362 LEU A 416 ASP A 427	ANP A 601 ( 4.6A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 (-3.2A) ANP A 601 (-4.1A) ANP A 601 ( 4.9A) MG A 603 ( 2.0A)	0.62A	4mkcA-4jrnA: 20.3	4mkcA-4jrnA: 22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MMD_B_29EB603_1 (TRANSPORTER)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	5 / 12	ASP A 535 VAL A 384 GLY A 197 SER A 391 SER A 390	None	1.17A	4mmdB-4jrnA: undetectable	4mmdB-4jrnA: 20.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_E_ADNE401_1 (CYCLIN-DEPENDENT KINASE 9)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	5 / 7	ALA A 279 ASP A 362 ASN A 414 LEU A 416 ASP A 427	ANP A 601 ( 3.9A) ANP A 601 (-4.1A) MG A 602 (-4.3A) ANP A 601 ( 4.9A) MG A 603 ( 2.0A)	0.79A	4ogrE-4jrnA: 21.0	4ogrE-4jrnA: 24.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WBO_C_ANWC601_0 (RHODOPSIN KINASE)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	4 / 6	LEU A 258 ALA A 279 MET A 356 LEU A 416	ANP A 601 ( 4.6A) ANP A 601 ( 3.9A) ANP A 601 (-3.3A) ANP A 601 ( 4.9A)	0.69A	4wboC-4jrnA: 18.9	4wboC-4jrnA: 23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AAA_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	6 / 9	LEU A 258 VAL A 266 ALA A 279 LEU A 416 GLY A 426 ASP A 427	ANP A 601 ( 4.6A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 ( 4.9A) None MG A 603 ( 2.0A)	0.68A	5aaaA-4jrnA: 20.2	5aaaA-4jrnA: 23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AAB_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	7 / 10	LEU A 258 VAL A 266 ALA A 279 LYS A 281 LEU A 416 GLY A 426 ASP A 427	ANP A 601 ( 4.6A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 (-3.2A) ANP A 601 ( 4.9A) None MG A 603 ( 2.0A)	0.89A	5aabA-4jrnA: 20.0	5aabA-4jrnA: 23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AAC_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	7 / 10	LEU A 258 VAL A 266 ALA A 279 LYS A 281 LEU A 416 GLY A 426 ASP A 427	ANP A 601 ( 4.6A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 (-3.2A) ANP A 601 ( 4.9A) None MG A 603 ( 2.0A)	0.89A	5aacA-4jrnA: 19.8	5aacA-4jrnA: 23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	4 / 7	GLY A 259 GLY A 261 VAL A 266 LYS A 281	ANP A 601 (-3.4A) ANP A 601 ( 3.3A) ANP A 601 (-4.1A) ANP A 601 (-3.2A)	0.45A	5izjA-4jrnA: 19.3	5izjA-4jrnA: 23.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	4 / 7	GLY A 259 GLY A 261 VAL A 266 LYS A 281	ANP A 601 (-3.4A) ANP A 601 ( 3.3A) ANP A 601 (-4.1A) ANP A 601 (-3.2A)	0.49A	5j5xA-4jrnA: 19.3	5j5xA-4jrnA: 23.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_H_ADNH401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	5 / 9	GLY A 259 VAL A 266 ALA A 279 MET A 356 LEU A 416	ANP A 601 (-3.4A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 (-3.3A) ANP A 601 ( 4.9A)	1.04A	5lw1H-4jrnA: 13.7	5lw1H-4jrnA: 12.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OAJ_E_TKTE601_1 ()	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	4 / 8	CYH A 198 TYR A 388 PHE A 424 ARG A 321	None	1.29A	5oajD-4jrnA: undetectable 5oajE-4jrnA: undetectable	5oajD-4jrnA: 20.16 5oajE-4jrnA: 20.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCY_A_DB8A401_1 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	6 / 12	LEU A 258 VAL A 266 ALA A 279 LYS A 281 GLU A 300 LEU A 354	ANP A 601 ( 4.6A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 (-3.2A) None None	0.57A	5vcyA-4jrnA: 21.3	5vcyA-4jrnA: 27.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X7P_A_ACRA1421_1 (GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	4 / 5	MET A 208 TYR A 388 GLY A 201 GLY A 421	None	0.99A	5x7pA-4jrnA: undetectable	5x7pA-4jrnA: 14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_A_1E8A1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	8 / 12	LEU A 258 GLY A 259 VAL A 266 ALA A 279 LYS A 281 LEU A 354 MET A 356 LEU A 416	ANP A 601 ( 4.6A) ANP A 601 (-3.4A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 (-3.2A) None ANP A 601 (-3.3A) ANP A 601 ( 4.9A)	0.92A	5yu9A-4jrnA: 18.7	5yu9A-4jrnA: 13.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_B_1E8B1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	7 / 12	GLY A 259 VAL A 266 ALA A 279 LYS A 281 LEU A 354 MET A 356 LEU A 416	ANP A 601 (-3.4A) ANP A 601 (-4.1A) ANP A 601 ( 3.9A) ANP A 601 (-3.2A) None ANP A 601 (-3.3A) ANP A 601 ( 4.9A)	0.96A	5yu9B-4jrnA: 18.8	5yu9B-4jrnA: 13.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CDU_I_EY4I500_0 (CHIMERIC ALPHA1GABAA RECEPTOR)	4jrn	RHOPTRY KINASE FAMILY PROTEIN (Toxoplasma gondii)	4 / 5	GLN A 401 VAL A 406 PRO A 522 THR A 430	None	1.49A	6cduI-4jrnA: undetectable 6cduJ-4jrnA: undetectable	6cduI-4jrnA: 19.42 6cduJ-4jrnA: 19.42

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1A52_B_ESTB2_1","ESTROGEN RECEPTOR","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",5,"ALA A 269;LEU A 278;MET A 356;ARG A 250;LEU A 258","None;None;ANP A 601 (-3.3A);None;ANP A 601 ( 4.6A)","1.46A","1a52B-4jrnA:undetectable","1a52B-4jrnA:20.31"],["1KVL_A_CLSA371_1","BETA-LACTAMASE","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",5,"GLY A 487;GLN A 505;TYR A 474;TYR A 491;THR A 483","None","1.43A","1kvlA-4jrnA:undetectable","1kvlA-4jrnA:21.29"],["1MUO_A_ADNA1_1","AURORA-RELATED KINASE 1","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",6,"LEU A 258;GLY A 259;VAL A 266;ALA A 279;ALA A 359;LEU A 416","ANP A 601 ( 4.6A);ANP A 601 (-3.4A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 (-3.5A);ANP A 601 ( 4.9A)","0.86A","1muoA-4jrnA:6.0","1muoA-4jrnA:26.34"],["1XBB_A_STIA1_1","TYROSINE-PROTEIN KINASE SYK","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",6,"LEU A 258;VAL A 266;ALA A 279;MET A 356;ALA A 359;LEU A 416","ANP A 601 ( 4.6A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 (-3.3A);ANP A 601 (-3.5A);ANP A 601 ( 4.9A)","0.89A","1xbbA-4jrnA:21.8","1xbbA-4jrnA:21.85"],["2DU8_B_BEZB1352_0","D-AMINO-ACID OXIDASE","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",4,"LEU A 389;TYR A 388;ILE A 204;ARG A 321","None","0.90A","2du8B-4jrnA:undetectable","2du8B-4jrnA:24.15"],["2EVA_A_ADNA498_1","TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",7,"GLY A 259;GLY A 261;VAL A 266;ALA A 279;MET A 356;ALA A 359;LEU A 416","ANP A 601 (-3.4A);ANP A 601 ( 3.3A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 (-3.3A);ANP A 601 (-3.5A);ANP A 601 ( 4.9A)","0.75A","2evaA-4jrnA:18.2","2evaA-4jrnA:24.03"],["2FUM_D_MIXD3539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",7,"LEU A 258;GLY A 259;GLY A 261;VAL A 266;ALA A 279;MET A 356;LYS A 411","ANP A 601 ( 4.6A);ANP A 601 (-3.4A);ANP A 601 ( 3.3A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 (-3.3A); MG A 602 (-3.6A)","0.86A","2fumD-4jrnA:19.6","2fumD-4jrnA:26.77"],["2ITY_A_IREA2020_1","EPIDERMAL GROWTH FACTOR RECEPTOR","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",9,"LEU A 258;GLY A 259;VAL A 266;ALA A 279;LYS A 281;GLU A 300;LEU A 354;LEU A 416;ASP A 427","ANP A 601 ( 4.6A);ANP A 601 (-3.4A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 (-3.2A);None;None;ANP A 601 ( 4.9A); MG A 603 ( 2.0A)","1.02A","2ityA-4jrnA:21.0","2ityA-4jrnA:24.88"],["2XP2_A_VGHA9000_1","TYROSINE-PROTEIN KINASE RECEPTOR","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",6,"LEU A 258;VAL A 266;ALA A 279;LEU A 416;GLY A 426;ASP A 427","ANP A 601 ( 4.6A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 ( 4.9A);None; MG A 603 ( 2.0A)","0.60A","2xp2A-4jrnA:19.9","2xp2A-4jrnA:23.47"],["3A9E_B_REAB1_1","RETINOIC ACID RECEPTOR ALPHA","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",5,"PHE A 322;ILE A 405;PHE A 307;SER A 308;PHE A 428","None","1.13A","3a9eB-4jrnA:undetectable","3a9eB-4jrnA:22.19"],["3DH0_A_SAMA220_1","SAM DEPENDENT METHYLTRANSFERASE","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",4,"ARG A 299;ASP A 465;GLN A 468;GLU A 450","None","1.13A","3dh0A-4jrnA:undetectable","3dh0A-4jrnA:21.41"],["3FUP_B_MI1B1_1","TYROSINE-PROTEIN KINASE JAK2","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",7,"LEU A 258;GLY A 259;GLY A 261;VAL A 266;ALA A 279;LYS A 281;MET A 356","ANP A 601 ( 4.6A);ANP A 601 (-3.4A);ANP A 601 ( 3.3A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 (-3.2A);ANP A 601 (-3.3A)","0.54A","3fupB-4jrnA:20.6","3fupB-4jrnA:19.74"],["3SUF_B_SUEB1201_2","NS3 PROTEASE, NS4A PROTEIN","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",3,"TYR A 267;LEU A 417;ARG A 358","None","0.67A","3sufB-4jrnA:undetectable","3sufB-4jrnA:20.56"],["3ZBF_A_VGHA3000_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",6,"LEU A 258;ALA A 279;ASP A 362;LEU A 416;GLY A 426;ASP A 427","ANP A 601 ( 4.6A);ANP A 601 ( 3.9A);ANP A 601 (-4.1A);ANP A 601 ( 4.9A);None; MG A 603 ( 2.0A)","0.56A","3zbfA-4jrnA:21.1","3zbfA-4jrnA:23.23"],["4ANS_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",6,"LEU A 258;VAL A 266;ALA A 279;MET A 356;LEU A 416;ASP A 427","ANP A 601 ( 4.6A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 (-3.3A);ANP A 601 ( 4.9A); MG A 603 ( 2.0A)","0.53A","4ansA-4jrnA:19.8","4ansA-4jrnA:24.23"],["4MKC_A_4MKA1503_1","ALK TYROSINE KINASE RECEPTOR","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",7,"LEU A 258;VAL A 266;ALA A 279;LYS A 281;ASP A 362;LEU A 416;ASP A 427","ANP A 601 ( 4.6A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 (-3.2A);ANP A 601 (-4.1A);ANP A 601 ( 4.9A); MG A 603 ( 2.0A)","0.62A","4mkcA-4jrnA:20.3","4mkcA-4jrnA:22.42"],["4MMD_B_29EB603_1","TRANSPORTER","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",5,"ASP A 535;VAL A 384;GLY A 197;SER A 391;SER A 390","None","1.17A","4mmdB-4jrnA:undetectable","4mmdB-4jrnA:20.60"],["4OGR_E_ADNE401_1","CYCLIN-DEPENDENT KINASE 9","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",5,"ALA A 279;ASP A 362;ASN A 414;LEU A 416;ASP A 427","ANP A 601 ( 3.9A);ANP A 601 (-4.1A); MG A 602 (-4.3A);ANP A 601 ( 4.9A); MG A 603 ( 2.0A)","0.79A","4ogrE-4jrnA:21.0","4ogrE-4jrnA:24.82"],["4WBO_C_ANWC601_0","RHODOPSIN KINASE","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",4,"LEU A 258;ALA A 279;MET A 356;LEU A 416","ANP A 601 ( 4.6A);ANP A 601 ( 3.9A);ANP A 601 (-3.3A);ANP A 601 ( 4.9A)","0.69A","4wboC-4jrnA:18.9","4wboC-4jrnA:23.19"],["5AAA_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",6,"LEU A 258;VAL A 266;ALA A 279;LEU A 416;GLY A 426;ASP A 427","ANP A 601 ( 4.6A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 ( 4.9A);None; MG A 603 ( 2.0A)","0.68A","5aaaA-4jrnA:20.2","5aaaA-4jrnA:23.47"],["5AAB_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",7,"LEU A 258;VAL A 266;ALA A 279;LYS A 281;LEU A 416;GLY A 426;ASP A 427","ANP A 601 ( 4.6A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 (-3.2A);ANP A 601 ( 4.9A);None; MG A 603 ( 2.0A)","0.89A","5aabA-4jrnA:20.0","5aabA-4jrnA:23.47"],["5AAC_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",7,"LEU A 258;VAL A 266;ALA A 279;LYS A 281;LEU A 416;GLY A 426;ASP A 427","ANP A 601 ( 4.6A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 (-3.2A);ANP A 601 ( 4.9A);None; MG A 603 ( 2.0A)","0.89A","5aacA-4jrnA:19.8","5aacA-4jrnA:23.47"],["5IZJ_G_AZ1G2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",4,"GLY A 259;GLY A 261;VAL A 266;LYS A 281","ANP A 601 (-3.4A);ANP A 601 ( 3.3A);ANP A 601 (-4.1A);ANP A 601 (-3.2A)","0.45A","5izjA-4jrnA:19.3","5izjA-4jrnA:23.75"],["5J5X_B_AZ1B2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAL-DAR-DAR-DAR-DAR","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",4,"GLY A 259;GLY A 261;VAL A 266;LYS A 281","ANP A 601 (-3.4A);ANP A 601 ( 3.3A);ANP A 601 (-4.1A);ANP A 601 (-3.2A)","0.49A","5j5xA-4jrnA:19.3","5j5xA-4jrnA:23.75"],["5LW1_H_ADNH401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",5,"GLY A 259;VAL A 266;ALA A 279;MET A 356;LEU A 416","ANP A 601 (-3.4A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 (-3.3A);ANP A 601 ( 4.9A)","1.04A","5lw1H-4jrnA:13.7","5lw1H-4jrnA:12.83"],["5OAJ_E_TKTE601_1",";","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",4,"CYH A 198;TYR A 388;PHE A 424;ARG A 321","None","1.29A","5oajD-4jrnA:undetectable;5oajE-4jrnA:undetectable","5oajD-4jrnA:20.16;5oajE-4jrnA:20.16"],["5VCY_A_DB8A401_1","MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",6,"LEU A 258;VAL A 266;ALA A 279;LYS A 281;GLU A 300;LEU A 354","ANP A 601 ( 4.6A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 (-3.2A);None;None","0.57A","5vcyA-4jrnA:21.3","5vcyA-4jrnA:27.34"],["5X7P_A_ACRA1421_1","GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",4,"MET A 208;TYR A 388;GLY A 201;GLY A 421","None","0.99A","5x7pA-4jrnA:undetectable","5x7pA-4jrnA:14.81"],["5YU9_A_1E8A1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",8,"LEU A 258;GLY A 259;VAL A 266;ALA A 279;LYS A 281;LEU A 354;MET A 356;LEU A 416","ANP A 601 ( 4.6A);ANP A 601 (-3.4A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 (-3.2A);None;ANP A 601 (-3.3A);ANP A 601 ( 4.9A)","0.92A","5yu9A-4jrnA:18.7","5yu9A-4jrnA:13.81"],["5YU9_B_1E8B1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",7,"GLY A 259;VAL A 266;ALA A 279;LYS A 281;LEU A 354;MET A 356;LEU A 416","ANP A 601 (-3.4A);ANP A 601 (-4.1A);ANP A 601 ( 3.9A);ANP A 601 (-3.2A);None;ANP A 601 (-3.3A);ANP A 601 ( 4.9A)","0.96A","5yu9B-4jrnA:18.8","5yu9B-4jrnA:13.81"],["6CDU_I_EY4I500_0","CHIMERIC ALPHA1GABAA RECEPTOR","4jrn","RHOPTRY KINASE FAMILY PROTEIN","Toxoplasma gondii",4,"GLN A 401;VAL A 406;PRO A 522;THR A 430","None","1.49A","6cduI-4jrnA:undetectable;6cduJ-4jrnA:undetectable","6cduI-4jrnA:19.42;6cduJ-4jrnA:19.42"]]